Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPEU.L Regulatory News (DPEU)

  • There is currently no data for DPEU

Shareholder Update

29 Oct 2021 09:32

RNS Number : 7206Q
DP Eurasia N.V
29 October 2021
 

For Immediate Release

29 October 2021

 

 

Shareholder Update

 

DP Eurasia N.V.

(DP Eurasia or the Company, and together with its subsidiaries, the Group)

 

Further to the announcement on 27 October 2021, the committee of the board of the Company (the "Independent Committee"), comprising all the independent directors, being the Chairman of the Board of DP Eurasia, Peter Williams, and the Senior Independent Non-Executive Director, David Adams, provides an update following feedback from shareholders who are eligible to tender their shares into the reverse bookbuild by Jubilant Foodworks Netherlands B.V. ("Jubilant") (the "RBB").

Feedback from shareholders

The Independent Committee has consulted with a number of shareholders eligible to tender into the RBB.

· Shareholders representing 42.4% of total issued share capital (and 63.0% of total issued share capital excluding shares owned by Jubilant) have not tendered and have provided their written intention not to tender.

· The Independent Committee is mindful that, of the balance, a significant proportion has not been consulted on the assumption of ineligibility to tender.

· No shareholder with whom the Independent Committee has consulted has indicated to them an intention to tender any shares.

Given the impact of certain shareholders' decisions on other shareholders, the Independent Committee believes that it is in the best interests of all shareholders for this information to be fully communicated prior to shareholders making their final decision as to whether or not to tender.

 

Recommendation

 

The Independent Committee maintains its recommendation that shareholders do not tender their shares under the RBB as further set out in the Company's announcement of 27 October 2021.

 

Enquiries

DP Eurasia N.V.

 

Selim Kender, Chief Strategy Officer & Head of Investor Relations

+90 212 280 9636

 

 

Buchanan (Financial Communications)

 

Richard Oldworth / Victoria Hayns / Tilly Abraham / Verity Parker

+44 20 7466 5000

dp@buchanan.uk.com

Liberum (Financial Adviser and Corporate Broker)

M&A: Tim Medak/Mark Harrison

Corporate Broking: Andrew Godber/Edward Thomas

 

 

+44 20 3100 2000

Notes to Editors

 

DP Eurasia N.V. is the exclusive master franchisee of the Domino's Pizza brand in Turkey, Russia, Azerbaijan and Georgia. The Company was admitted to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc on 3 July 2017. The Company (together with its subsidiaries, the "Group") is the largest pizza delivery company in Turkey and the third largest in Russia. The Group offers pizza delivery and takeaway/ eat-in facilities at its 789 stores (584 in Turkey, 192 in Russia, nine in Azerbaijan and four in Georgia as at 30 June 2021), and operates through its owned corporate stores (28%) and franchised stores (72%). The Group maintains a strategic balance between corporate and franchised stores, establishing networks of corporate stores in its most densely populated areas to provide a development platform upon which to promote best practice and maximise profitability. The Group has adapted the Domino's Pizza globally proven business model to its local markets. 

Important Notices

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser exclusively for the Company and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Liberum, nor for providing advice in relation to the contents of this announcement or any other matter referred to herein. Neither Liberum nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Liberum in connection with this announcement, any statement contained herein or otherwise. Neither Liberum nor any of its affiliates nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company.

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of the Company who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of the Company who are not resident in the United Kingdom will need to inform themselves about, and observe any applicable requirements.

Forward-looking statements

This document, including information included or incorporated by reference in this document, may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. There are many factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among such factors are changes in the global, political, social, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates, future business combinations or disposals, and any epidemic, pandemic or disease outbreak.

These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate in the future. By their nature, these forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this document may cause the actual results, performance or achievements of any such person, or industry results and developments, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. No assurance can be given that such expectations will prove to have been correct and persons reading this document are therefore cautioned not to place undue reliance on these forward-looking statements that speak only as at the date of this document. All subsequent oral or written forward-looking statements attributable to the Company or its affiliates or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. The Company does not intend, nor undertakes any obligation, to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFESSAUEFSEDS
Date   Source Headline
25th Apr 202210:33 amRNSIntended Appointment of a New INED
22nd Apr 20229:45 amRNSPDMR and PCA Notification
22nd Apr 20227:00 amRNSPDMR and PCA Notification
13th Apr 20222:00 pmRNSResults of 2022 Extraordinary General Meeting
12th Apr 202210:24 amRNSPDMR and PCA Notification
6th Apr 20224:41 pmRNSSecond Price Monitoring Extn
6th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSPreliminary Results
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:36 pmRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSUpdate on Russian Operations
4th Mar 20223:12 pmRNSNotification of Major Holdings
4th Mar 20223:07 pmRNSPDMR and PCA Notification
4th Mar 20227:00 amRNSRussia/Ukraine Update & Notice of Results
28th Feb 20225:04 pmRNSNotice of Extraordinary General Meeting
16th Feb 20227:00 amRNSShareholder Update
10th Feb 202210:23 amRNSPDMR and PCA Notification
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:36 pmRNSPrice Monitoring Extension
7th Feb 20222:58 pmRNSPDMR and PCA Notification
26th Jan 20227:00 amRNSFY21 Trading Update
14th Jan 20227:00 amRNSNotice of Trading Update
10th Jan 20229:53 amRNSPDMR and PCA Notification
14th Dec 20217:00 amRNSNotification of Major Holdings
1st Dec 20214:35 pmRNSNotification of Major Holdings
30th Nov 20217:00 amRNSTrading Update: Continued strong momentum
19th Nov 20217:00 amRNSNotification of Major Holdings
12th Nov 20217:00 amRNSNotice of Trading Update
9th Nov 20212:24 pmRNSPDMR and PCA Notification
8th Nov 20217:00 amRNSShareholder Update
1st Nov 202110:48 amRNSShareholder Update
1st Nov 20217:00 amRNSResult of Reverse Bookbuild
29th Oct 20219:32 amRNSShareholder Update
27th Oct 20217:00 amRNSShareholder Update
21st Oct 20215:00 pmRNSNotification of Major Holdings
20th Oct 20213:54 pmRNSShareholder Update
20th Oct 20217:00 amRNSNotification of Major Holdings
1st Oct 202111:56 amRNSShareholder Update
30th Sep 20214:45 pmRNSReverse Bookbuild to acquire shares in DP Eurasia
27th Sep 20217:00 amRNSNotification of Major Holdings
7th Sep 20217:00 amRNSInterim Results
25th Aug 20217:00 amRNSNotification of Interim Results
14th Jul 20217:00 amRNSH1 Trading Update
1st Jul 20217:00 amRNSNotice of Trading Update
8th Jun 20211:45 pmRNSResults of 2021 Annual General Meeting
19th May 20214:32 pmRNSNotification of Major Holdings
18th May 20217:00 amRNSTrading Update
10th May 20217:00 amRNSNotice of Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.